These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 54965)

  • 1. Cross reactivity between H-2K and H-2D products. II. Identification of the cross reacting specificities.
    Murphy DB; Shreffler DC
    Transplantation; 1975 Dec; 20(6):443-56. PubMed ID: 54965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-reactivity between H-2K and H-2D products. I. Evidence for extensive and reciprocal serological cross-reactivity.
    Murphy DB; Shrefler DC
    J Exp Med; 1975 Feb; 141(2):374-91. PubMed ID: 1089744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunochemical evidence for an additional H-2 region closely linked to H-2D.
    Hansen TH; Cullen SE; Sachs DH
    J Exp Med; 1977 Feb; 145(2):438-42. PubMed ID: 64585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of T and B lymphocytes in vitro. III. Presence of Ia determinants on allogeneic effect factor.
    Armerding D; Sachs DH; Katz DH
    J Exp Med; 1974 Dec; 140(6):1717-22. PubMed ID: 4139236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Private specificities of H-2K and H-2D loci as possible selective targets for effector lymphocytes in cell-mediated immunity.
    Brondz BD; Egorov IK; Drizlikh GI
    J Exp Med; 1975 Jan; 141(1):11-26. PubMed ID: 46906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross reactivity between H-2K and H-2D products. III. Effect of H-2K-H-2D cross sensitization on skin graft survival.
    Murphy DB; Shreffler DC
    Transplantation; 1975 Jul; 20(1):38-44. PubMed ID: 52220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative immunogenicity and enhanceability of individual H-2K and H-2D specificities of the murine histocompatibility-2 complex.
    McKenzie IF; Snell GD
    J Exp Med; 1973 Jul; 138(1):259-77. PubMed ID: 4123828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibodies to mouse major histocompatibility complex antigens.
    Ozato K; Mayer NM; Sachs DH
    Transplantation; 1982 Sep; 34(3):113-20. PubMed ID: 7135466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of tumor-specific transplantation antigens to the histocompatibility complex: dissociation of in vitro alloantigen expression and in vivo alloimmunity from tumor-specific transplantation antigen strength.
    Chauvenet PH; Smith RT
    Int J Cancer; 1978 Jul; 22(1):79-90. PubMed ID: 79560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. H-2.28, an alloantigenic marker allelic to H-2.1, is expressed on all three known types of H-2 molecules.
    Démant P; Iványi D; Neauport-Sautes C; Snoek M
    Proc Natl Acad Sci U S A; 1978 Sep; 75(9):4441-5. PubMed ID: 81489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of H-2 antigens of wild mice (Mus musculus L.).
    Micková M; Iványi P
    Folia Biol (Praha); 1976; 12(3):169-89. PubMed ID: 62682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical nature of mouse histocompatibility antigens. II. Column chromatography separation of antigenic products of H-2K and H-2D genes.
    Koubek K; Hilgert I; Kristofová H
    Folia Biol (Praha); 1973; 19(6):397-401. PubMed ID: 4130567
    [No Abstract]   [Full Text] [Related]  

  • 13. Cytotoxic T lymphocytes specific for I region determinants do not require interactions with H-2K or D gene products.
    Billings P; Burakoff S; Dorf ME; Benacerraf B
    J Exp Med; 1977 May; 145(5):1387-92. PubMed ID: 67179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple CTL subsets generated by H-2.L locus products stimulation: evidence for an antigenic determinant private to H-2.Ld.
    Vazquez A; Senik A; Neauport-Sautes C
    J Immunol; 1980 Jul; 125(1):74-7. PubMed ID: 6155410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation in a new H-2-associated histocompatibility gene closely linked to H-2D.
    Hansen TH; Cullen SE; Melvold R; Kohn H; Flaherty L; Sachs DH
    J Exp Med; 1977 Jun; 145(6):1550-8. PubMed ID: 68094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serologic cross-reactivity between Class I MHC molecules and an H-2-linked differentiation antigen as detected by monoclonal antibodies.
    Sharrow SO; Flaherty L; Sachs DH
    J Exp Med; 1984 Jan; 159(1):21-40. PubMed ID: 6363595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxic T lymphocytes induced against allogeneic I-region determinants react with Ia molecules on trinitrophenyl-conjugated syngeneic target cells.
    Billings P; Burakoff S; Dorf ME; Benacerraf B
    J Exp Med; 1977 Aug; 146(2):623-8. PubMed ID: 69009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of T-cell-mediated lympholysis by the murine major histocompatibility complex. II. Control of cytotoxic responses to trinitrophenyl-K and -D self products by H-2K- and H-2D-Region genes.
    Levy RB; Shearer GM
    J Exp Med; 1980 Jan; 151(1):252-6. PubMed ID: 6153113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic control of the humoral response to an H-2 public specificity.
    Hansen TH; Cullen SE; Shinohara N; Schurko E; Sachs DH
    J Immunol; 1977 Apr; 118(4):1403-8. PubMed ID: 66293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The private specificity H-2.4 and the public specificity H-2.28 of the D region are expressed on two independent polypeptide chains.
    Neauport-Sautes C; Morello D; Freed JH; Nathenson SG; Démant P
    Eur J Immunol; 1977 Aug; 7(8):511-5. PubMed ID: 71238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.